Fresh Tracks Therapeutics Inc Investor Relations Material
Latest events
Q3 2022
Fresh Tracks Therapeutics Inc
Q4 2023
15 Mar, 2024
Q3 2023
13 Nov, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Fresh Tracks Therapeutics Inc
Access all reports
Fresh Tracks Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for autoimmune, inflammatory, and other skin-related diseases. The company's pipeline includes small molecule and biologic drug candidates designed to target the underlying causes of these conditions. Fresh Tracks aims to provide new treatment options that address unmet medical needs in dermatology and immunology. The company serves the healthcare sector, specifically focusing on skin health and immune system disorders. The company is headquartered in Boulder, Colorado, and its shares are listed on the NASDAQ.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
FRTX
Country
🇺🇸 United States